The landscape for cryptocurrency ETFs is evolving as the SEC, under new leadership, adopts a more open stance.
With Bitcoin and Ethereum ETFs already approved, interest is now turning to altcoins, sparking a wave of applications. Analysts believe Litecoin (LTC) has the best shot at approval, surpassing other contenders like Solana (SOL), XRP, and Dogecoin (DOGE).
A report from Bloomberg’s Eric Balchunas and James Seyffart outlined their projections for potential approvals. They estimate Litecoin has a 90% chance of getting the green light by early 2025, while Solana, XRP, and Dogecoin face slightly lower probabilities, with expected decisions later in the year.
Balchunas recently noted that the SEC’s willingness to consider XRP ETFs is a major shift, suggesting that some altcoins may no longer be classified as securities. This could impact ongoing legal battles and reshape regulatory attitudes toward the sector.
While optimism is growing, uncertainty remains. Balchunas pointed out that Dogecoin and Cardano could follow XRP’s path, but approval is far from guaranteed. Litecoin, however, stands apart due to its similarities to Bitcoin, making it the most likely to gain SEC approval in 2025.
As for Solana and XRP, the road ahead is less clear, but with the SEC now reviewing applications, more developments are expected in the coming months.
Binance has officially launched a new airdrop event for Verasity (VRA) through its Binance Alpha platform, giving eligible users the chance to claim free tokens and compete for a massive prize pool.
XRP has emerged from a months-long consolidation with renewed bullish momentum, reigniting trader interest in its next major price target.
Despite recent gains across select DeFi and RWA tokens, Bitcoin continues to dominate the crypto landscape, with the Altcoin Season Index sitting at 43/100, according to today’s CoinMarketCap data.
XRP is back in the spotlight after crypto analyst EGRAG CRYPTO highlighted a powerful historical pattern on the weekly timeframe—the bullish crossover of the 21 EMA and 55 SMA.